sdfsssssssssssssssssssssssssssdfffffffffdsf

dsffffffffffff

1. Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy (HCM) is defined as the presence of increased LV wall thickness (with or without RV hypertrophy) or mass that is not solely explained by abnormal loading conditions.

2. Hypertrophic cardiomyopathy in an adult, HCM is defined by an LV wall thickness ≥ 15 mm in any myocardial segment that is not explained solely by loading conditions. Lesser degrees of wall thickening (13–14 mm) require evaluation of other features including family history, genetic findings, and ECG abnormalities. DIAGNOSTIC

3. 3 Hypertrophic cardiomyopathy

4. 4 Hypertrophic cardiomyopathy

5. 5 Hypertrophic cardiomyopathy

6. 6 Hypertrophic cardiomyopathy LABORATORIUM

7. Hypertrophic cardiomyopathy 7 MRI

8. SUMMARY 8

9. Atrial fibrillation is the most common arrhythmia in all subtypes of cardiomyopathies and is associated with an increased risk of cardio-embolic events, heart failure, and death 9

10. AntiCoagulation 10

11. 11 Rate control

12. AREAS OF FOCUS 12

13. Hypertrophic cardiomyopathy

14. 14 Hypertrophic cardiomyopathy

15. Presentation title 15

16. SEPTAL REDUCTION TERAPHY Presentation title 16

17. NON DILATED CARDIOMYOPATHY The non-dilated LV cardiomyopathy phenotype is defined by the presence of non- ischaemic LV scarring in the absence of LV dilatation, with or without global or regional wall motion abnormalities, or isolated global LV hypokinesia without scarring By the presence of LGE on CMR) Global LV systolic dysfunction is defined by abnormal LVEF (i.e. <50%) Presentation title 17

18. 19

19. Arrhythmogenic right ventricular cardiomyopathy 20

20. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized structurally by a progressive myocardial atrophy with fibro-fatty replacement of the RV myocardium. 21

21. Presentation title 22

22. Presentation title 23

23. THANK YOU